US company launches condom made with Vytex
ERJ staff report (DS)
Atlanta. Georgia -- Vystar Corp. and Alatech Healthcare, LLC said theyhave FDA clearance to market and sell Alatech's Envy condom manufactured with Vytex. The Envy condom will be the first medical product available in the US made from Vystar's patented Vytex NRL.
Vystar, which produces Vytex, said its material contains less than 2 micrograms/dm2, virtually undetectable levels, of the antigenic proteins that can cause an allergic response, while retaining and improving upon all the desirable qualities of latex.
The Envy condom will carry labeling that will reflect the lowest antigenic protein content currently available in a natural rubber latex medical device in the US. Natural rubber latex contains over 200 proteins, similar to other natural plant materials, of which 13 are known allergens. The Vytex NRL process was created to significantly reduce these known proteins. Vystar's business model is to assist all manufacturers in marketing the Vytex component of their products.
This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.
Press release from Vystar
This article is only available to subscribers - subscribe today
Subscribe for unlimited access. A subscription to European Rubber Journal includes:
- Every issue of European Rubber Journal (6 issues) including Special Reports & Maps.
- Unlimited access to ERJ articles online
- Daily email newsletter – the latest news direct to your inbox
- Access to the ERJ online archive